Cognitive Bias Modification for Obsessive-Compulsive Disorder
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Cognitive Bias Modification for Obsessive-Compulsive Disorder?
Research shows that Cognitive Bias Modification (CBM) can help change biased thinking patterns linked to various mental health issues, including obsessive-compulsive disorder (OCD). Studies have found that CBM can effectively target and modify interpretation biases, which are thought to play a role in maintaining OCD symptoms.12345
Is Cognitive Bias Modification (CBM) safe for humans?
How is the treatment CBM-TAF different from other treatments for OCD?
CBM-TAF is unique because it focuses on changing the way people interpret their thoughts and actions through computerized tasks, aiming to reduce biased thinking patterns associated with OCD. Unlike traditional therapies, it uses technology to 're-train' the brain's automatic responses, potentially offering a new way to address the underlying cognitive biases in OCD.134910
What is the purpose of this trial?
Thought-Action-Fusion (TAF) is a cognitive bias that posits (1) having unwanted thoughts is morally equivalent to acting upon the thoughts (TAF-Moral; e.g., "Thinking about harming a child is as immoral as actually harming a child") and (2) having unwanted thoughts will increase the likelihood of the thoughts happening in real life (TAF-Likelihood; e.g., "My mother will get into a car accident, because I thought about it"). Given its central role in the development and maintenance of OCD, TAF has emerged as a potential treatment target for obsessive-compulsive disorder (OCD). Previous research has demonstrated that TAF is indeed a malleable construct. This study aims to examine the effects of a multi-session, personalized cognitive bias modification (CBM) for thought-action-fusion (TAF) on improving obsessive-compulsive (OC) symptoms in a college sample.
Research Team
Hanjoo Lee, PhD
Principal Investigator
University of Wisconsin, Milwaukee
Eligibility Criteria
This trial is for college individuals with Obsessive-Compulsive Disorder (OCD) who experience Thought-Action-Fusion, where they believe unwanted thoughts are morally wrong or likely to become real. Specific eligibility criteria details were not provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 6 training sessions over 3 weeks, focusing on cognitive bias modification for Thought-Action-Fusion or stress management
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- CBM-SMP
- CBM-TAF
Find a Clinic Near You
Who Is Running the Clinical Trial?
Han Joo Lee
Lead Sponsor
Psi Chi
Collaborator
Psi Chi
Collaborator